Charles River Labs: Barclays raises target price to $375 from $330
CRL•Barclays raised its target price for Charles River Labs to $375 from $330.
Related News
Aspen Aerogels Q3 EPS USD -0.13
ASPN•
Viridian Therapeutics target price raised to $34 from $31 by Wells Fargo
VRDN•
BeOne Medicines raises 2026 revenue guidance to $6.9 billion-$7 billion
ONC•
Diageo reiterates fiscal 2027 outlook for broadly flat organic net sales growth
DEO•
Angel Oak Mortgage REIT, Inc.: Wells Fargo cuts target price to $8 from $10
AOMR•